Comparison of ursodeoxycholic acid 900 mg/day and 1200 mg/day for chronic hepatitis C patients

Phase 1

Recruiting

• Conditions: chronic hepatitis C

• Registration Number: JPRN-UMIN000001471
• Lead Sponsor: Department of Gastroenterology, the University of Tokyo Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-12-01
• Study Completion: 2011-03-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

decompensated cirrhosis under anti-viral therapy complete biliary obstruction pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
decrease in serum ALT levels

Secondary Outcome Measures

Name	Time	Method
adverse events